chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next day the whole area was red and smooth; The next day whole area was red and smooth and very mild itchiness; A patchy bumpy rash around the injection site; A patchy bumpy rash around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 13:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy. The patient had known allergies to food (mushroom). Concomitant medications included womens health vitamins for unknown indication and levocetirizine dihydrochloride (XYZAL) for allergy, on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 12:00, 1 week and 1 day after vaccine; 8 days after, the patient experienced patchy bumpy rash around the injection site. On 11Apr2021, 9 days after vaccination, next day, the patient experienced whole area was red and smooth and very mild itchiness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event's patchy bumpy rash around the injection site, whole area was red and smooth and very mild itchiness was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
This infant's right leg turned purple on the day of the shot. Also her right leg was shaking, she had a hi fever of 101F, seen in the ED , given Tylenol etc and sent home. The patient moves her right leg well no abscess.
5 days after vaccination toothache on left side of mouth, 9 days after vaccination left elbow achy, 10 days after vaccination all joints on left side of body achy, joints on right side of body achy to a lesser degree. 11 days after vaccincation all joints in body very achy felt like body was under attacke. 12 Days after vaccination achiness began to subside. 18 days after vaccination achiness continues to be present. I had not experienced joint achiness prior to receiving the vaccine.
Vaccine administered evening of 1/25/21;  Late afternoon of 2/2/21 I developed a localized reaction (referred to as ?COVID Arm?). There is mild itching, mild to moderate swelling, redness & ?chicken skin? hives, and moderate/moderate to severe pain, tenderness, soreness at the site, and spreading down to my hand, up to my neck, and down to my shoulder blade. It is warm to the touch as well.  I feel cold, but do not have a fever, am not having chills, nausea, etc.
Information has been received from a medical assistant concerning a 3 year, 6 month old patient who was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy included varicella virus vaccine live. Other concomitant therapy included DURA-TAP/PD. Subsequently, the patient experienced swelling in both arms after receiving measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3), varicella virus vaccine live (MSD) vaccines and DURA-TAP/PD. The patient was brought back in the office 2 days post vaccination and treated with topical cream. No lot number was provided. Additional information has been requested.
Vaccine was refrigerated on 31-Aug-2021, expired on 22-Sep-2021 and was administered on 24-Sep-2021.; doses that were expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses that were expired) and PRODUCT STORAGE ERROR (Vaccine was refrigerated on 31-Aug-2021, expired on 22-Sep-2021 and was administered on 24-Sep-2021.) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses that were expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was refrigerated on 31-Aug-2021, expired on 22-Sep-2021 and was administered on 24-Sep-2021.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses that were expired) and PRODUCT STORAGE ERROR (Vaccine was refrigerated on 31-Aug-2021, expired on 22-Sep-2021 and was administered on 24-Sep-2021.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial was initially stored in the refrigerator on 31-Aug-2021. The vial did not undergo any temperature excursions.  No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2022-534284 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2022: Follow up received contains non significant information.
BLOOD CLOTS IN RIGHT ARM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included Blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose not reported, 1 total administered on an unspecified date for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced blood clots in right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots in right arm was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20220411946- covid-19 vaccine ad26.cov2.s Blood clots in right arm. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY. Therefore, this event(s) is considered not related.
PUKED WHOLE NIGHT; HIGH FEVER OVER 40 CELCIUS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced puked whole night, and high fever over 40 celcius. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) High fever over 40 celcius. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the puked whole night and high fever over 40 celcius was not reported. This report was non-serious.
The patient presented to the clinic on 08/22/2022 c/o of pain 10/10, swelling, and hot to touch at the injection site. The patient was vaccinated on 8/19/2022 and stated symptoms started on 8/20/2022, pt took over-the-counter medication for swelling and pain. The patient had  Cephalexin 500 mg prescribed on 8/22/2022. The patient then returned to the clinic on 8/24/22 complaining of persistent pain at the injection site and swelling, the patient stated she is still taking antibiotics and ibuprofen. The patient was advised to go to the emergency department for persisting symptoms.
I have been in menopause for a few years and have not had a period for 3 years. I had vaginal bleeding that was slow then turned strong and heavy. I went to my OBGYN and had a vaginal ultrasound and also did a biopsy. I had blood work to see if I was anemic. I was told to rest due to the bleeding being so heavy. Today, it has slowed down some. I was going to be put on progesterone but had to wait to see if I was anemic. I have a follow up appt coming up and a possible second biopsy.
20 minutes after vaccine injection Patient C/O tongue tingling, feeling swollen and puffy eyes. Patient mildly swollen around eyes. VS Stable. IM Benadryl 50MG administered to right deltoid. O2 at 2L per NC administered. Improved for 10 minutes and then tingling and swelling returned. C/O of feeling lightheaded.  Medicated with Epi pen to left thigh. Patient improved/stable and was sent via EMS to hospital for evaluation and treatment.
8/15/21: patient admitted from ED Obs to med/tele COVID unit.  He states that he had the Pfizer vaccine, 2 doses in January 2021.  He was previously seen at ED on 08/07 and tested negative for COVID at that time, but his wife had tested positive.  He went back to ER on 8/15/21 because he was still short of breath and coughing and tested positive for COVID.  Patient did get Regeneron on 8/15.   8/15/21: admitted, diagnosed with acute respiratory insufficiency requiring oxygen therapy. 8/17/2021: patient discharged
13AUG91 130PM unconsolable crying since recvd shot this AM & swelling @ rt thigh, t99.4 R; Given APAP; Advised to bring pt to clinic would evaluate/refer to ER; consulted MD via phone; fussy, severe diaper rash noted;
2 days later my arm is hot, firm, with a circular red blotchy trash. It is itchy and tender. It feels tight.
Swollen lymph gland under right arm 4 days. Shooting burning pain in left breast every night for about 30 seconds. This started 11/27/2021. This is still happening. Breast tenderness throughout the day also.
"Felt like a bee sting exactly 24 hours after I got the vaccine."  A 3 centimeter raised red circumference was noted on the left arm tricep area.  It has a dark center (slighly purple in color). It is painful.  Is taking Benadryl at night to help with the reaction.
Patient received Tdap vaccine on 1/25/2018. The next day she reported to administering nurse that she felt clammy, had a metallic taste in her mouth, and her fingers felt tingly. There was no indication of trouble breathing or more serious allergic symptoms. When the nurse followed up with the patient the next day the patient reported some urticarial on her abdomen that had improved since she had taken some diphenhydramine earlier.
Pt received Pfizer vaccine at 2:30pm. At 2:35 patient began feeling chest heaviness and nausea. Pt vitals taken: BP 150/90, HR 87, O2 97, respirations 18. Pt sent to EMS and given 324mg aspirin, vitals: NP 172/108, HR 92, O2 97% RA, resp. 18. EMS gave 0.4mg nitrogycerin PO x1. Chest heaviness resolved with nitro. Pt recommended to go to hospital for ER evaluation. Pt agreed. Pt transported via ambulance to hospital.
Flulike symptoms -- body aches,  fever, fatigue  -- lasting around 36 hours
Pt had Pfizer for dose 1 of series. Pt was inadvertently given Moderna 0.5 ml for dose 2.
Left ear tinnitus that started with the 4th booster in March after 5 days and got better ( not resolved ) by November got significantly worse after bivalent booster on Nov 23 ( the left ear tinnitus shot up within 30 minutes ) of injection with Pfizer shot in the left arm.
09/08/22 presents to ED for "abscess to his back". PMHx of "diabetes, hypertension, obesity"
mom contacted pvt MD who told her to go to ER mom told clinic that pt had fever of 105 & was extremely irritable x 6hrs;pt was seen in ER given Ibuprofen & discharged
Big Lump under the left Arm (Armpit) about 2" Inches in Size; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (Big Lump under the left Arm (Armpit) about 2" Inches in Size) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced AXILLARY MASS (Big Lump under the left Arm (Armpit) about 2" Inches in Size). At the time of the report, AXILLARY MASS (Big Lump under the left Arm (Armpit) about 2" Inches in Size) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Large rash developed a couple of days after injection. It was below the injection site and itched considerably. I thought it might be related to my eczema so I treated it with Triamcinolone Acetonide. Rash and itching went away after 2-3 days.
A parent of a child who recv vax reporter the child did not exp rash; however, the adult parent exp secondary transmission of herpes zoster;the adult parent had a hx of chickenpox in the past;
Pt reported Dizziness and stated he had not had any water today. VSS. A and O x3. Resolved with water intake at 1504pm
Information has been received from a physician concerning an 18 year old female who was vaccinated on an unspecified day with HPV rL1 6 11 16 18 VLP vaccine (yeast) and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid(manufacturer unknown). The patient experienced swollen glands the day after the vaccination and went to the ER for unspecified medical treatment. Per the doctor the patient recovered. Additional information has been requested. Initial and follow up information has been received from a physician concerning an 18 year old female with asthma and allergic rhinitis who on 12-OCT-2007 was vaccinated with her first dose of HPV (Lot #655165/1425F) and DTAP (manufaturer unknown). On 12-OCT-2007 the patient developed swollen glands and was seen at the emergency room complaining of painful left side supraclavicular nodule. The patient was seen again on 13-OCT-2007 at t he office and on 1-NOV-2007 the adenopathy was resolved. Labs included CBC, chest x-ray, and chest CT scan - no results were given for any of the lab tests. No further information is expected.
Very low fever and fatigue the day after the injection, but swollen rash on injection site arm starting around 12 days after (might have been a little earlier, but only got truly noticeable by about 29th for a shot given on the 17th)
9/2 experienced stinging and pins and needle feeling in my lower face (chin and cheek area)  when touched. Experienced off and on for a few weeks.   Monthly period  started a week early 9/27. Bled heavily for a week. Was off of my period for a week and started again with heavy bleeding 10/11. Extremely heavy flow for the past few days, feeling feverish, with headache and tired.   I still have a slight bruise on my arm where the vaccine was administered a month and a half ago.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a currently 75-year-old female patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 2014, at the age of approximately 71-year-old, the patient was administered with zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions (lot#, expiration date, dosage and route of administration not specified). On an unknown date, the patient was treated by a physician for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: shingles. At the time of the report, the outcome of shingles was unknown. The reporter considered that shingles was related to Zoster Vaccine Live (ZOSTAVAX).   Additional information has been requested.
Aches; Pain in the arm; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headaches) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 13F21A, 007B21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Aches), PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headaches). At the time of the report, PAIN (Aches), PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headaches) outcome was unknown.            Concomitant and treatment medications were not provided.
Patient covid positive; Patient covid positive; feel body pains; fatigue; fever (37.8C); Cough; This is a spontaneous report from a contactable consumer (reported for himself). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6205/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on an unspecified date (at the age of 40-years-old) as dose 1, single and dose 2 via an unspecified route of administration on an unspecified date (Lot Number: EW0158/Batch number was not reported) as dose 2, single for covid-19 immunisation at other. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient experienced feel body pains, fatigue, fever (37.8 Centigrade), cough on 16Aug2021 and patient covid positive on 18Aug2021. The event patient covid positive assessed as serious (medically significant). The patient underwent lab tests and procedures which included body temperature: 37.8 Centigrade on 16Aug2021 and sars-cov-2 test: positive on 18Aug2021 (nasal swab). The outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a Licensed Practical Nurse refers to patients of unknown demographics. On an unknown date, an unspecified number of patients received improperly stored (Oka/Merck) VARIVAX (dose details, lot number unspecified). No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This case is also related to 1507USA007760, 1507USA007761 and 1507USA001935 (same reporter link). Additional information has been requested.
having extreme pain in her thumb on the same hand from the same arm in which she was administered the second vaccine; This is a spontaneous report from a contactable consumer medical information team. This consumer reported for a female patient (Wife). A female patient received bnt162b2 (BNT162B2), administered in arm (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERER UNKNOWN), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "having extreme pain in her thumb on the same hand from the same arm in which she was administered the second vaccine".  Additional information: Case narrative: Is Unspecified Vaccine a Pfizer product: Unspecified. Vaccine manufacturer was unspecified. Dates for Unspecified Vaccine was unspecified. NDC, Expiry Date and UPC number of Unspecified Vaccine was Unknown. Reason for no lot number: of Unspecified Vaccine: Not probed over call. Product: PFIZER-BIONTECH COVID-19 VACCINE. Additional Context: Reporter was Husband. Reporter mentioned " Reporter actually filed a report for his wife under the Pfizer reporting website, and she is having a problem with, after the second vaccine she is having extreme pain in her thumb on the same hand from the same arm in which she was administered the second vaccine. We wanted to kind of, like he said, he filled that report on the website and wanted to see what best next steps were.". Reporter mentioned "If its the same questions as he report he filled already, then he already did that."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
my arm turned beet red; arm started to itch; swollen; hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch). On 30-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (my arm turned beet red). At the time of the report, INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.